vs

Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Fat Brands, Inc (FAT). Click either name above to swap in a different company.

COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $140.0M, roughly 1.5× Fat Brands, Inc). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs -41.6%, a 49.8% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs -2.3%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $-16.9M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs -6.1%).

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.

FAT Brands Inc. is an American multi-brand restaurant and sports bar franchise operator headquartered in Beverly Hills, California.

COLL vs FAT — Head-to-Head

Bigger by revenue
COLL
COLL
1.5× larger
COLL
$205.4M
$140.0M
FAT
Growing faster (revenue YoY)
COLL
COLL
+15.3% gap
COLL
12.9%
-2.3%
FAT
Higher net margin
COLL
COLL
49.8% more per $
COLL
8.3%
-41.6%
FAT
More free cash flow
COLL
COLL
$139.2M more FCF
COLL
$122.4M
$-16.9M
FAT
Faster 2-yr revenue CAGR
COLL
COLL
Annualised
COLL
19.1%
-6.1%
FAT

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
COLL
COLL
FAT
FAT
Revenue
$205.4M
$140.0M
Net Profit
$17.0M
$-58.2M
Gross Margin
62.5%
Operating Margin
29.6%
-12.4%
Net Margin
8.3%
-41.6%
Revenue YoY
12.9%
-2.3%
Net Profit YoY
35.3%
-30.1%
EPS (diluted)
$0.48
$-3.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COLL
COLL
FAT
FAT
Q4 25
$205.4M
Q3 25
$209.4M
$140.0M
Q2 25
$188.0M
$146.8M
Q1 25
$177.8M
$142.0M
Q4 24
$181.9M
$145.3M
Q3 24
$159.3M
$143.4M
Q2 24
$145.3M
$152.0M
Q1 24
$144.9M
$152.0M
Net Profit
COLL
COLL
FAT
FAT
Q4 25
$17.0M
Q3 25
$31.5M
$-58.2M
Q2 25
$12.0M
$-54.2M
Q1 25
$2.4M
$-46.0M
Q4 24
$12.5M
$-67.4M
Q3 24
$9.3M
$-44.8M
Q2 24
$19.6M
$-39.4M
Q1 24
$27.7M
$-38.3M
Gross Margin
COLL
COLL
FAT
FAT
Q4 25
62.5%
Q3 25
61.7%
Q2 25
57.7%
Q1 25
54.8%
Q4 24
54.0%
Q3 24
60.8%
Q2 24
62.5%
Q1 24
63.1%
Operating Margin
COLL
COLL
FAT
FAT
Q4 25
29.6%
Q3 25
29.7%
-12.4%
Q2 25
18.7%
-10.6%
Q1 25
12.2%
-6.0%
Q4 24
20.9%
-27.1%
Q3 24
21.9%
-6.2%
Q2 24
32.7%
-1.8%
Q1 24
34.1%
-0.9%
Net Margin
COLL
COLL
FAT
FAT
Q4 25
8.3%
Q3 25
15.0%
-41.6%
Q2 25
6.4%
-36.9%
Q1 25
1.4%
-32.4%
Q4 24
6.9%
-46.4%
Q3 24
5.9%
-31.2%
Q2 24
13.5%
-25.9%
Q1 24
19.1%
-25.2%
EPS (diluted)
COLL
COLL
FAT
FAT
Q4 25
$0.48
Q3 25
$0.84
$-3.39
Q2 25
$0.34
$-3.17
Q1 25
$0.07
$-2.73
Q4 24
$0.36
$-4.06
Q3 24
$0.27
$-2.74
Q2 24
$0.52
$-2.43
Q1 24
$0.71
$-2.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COLL
COLL
FAT
FAT
Cash + ST InvestmentsLiquidity on hand
$386.7M
Total DebtLower is stronger
$1.3B
Stockholders' EquityBook value
$301.7M
$-585.8M
Total Assets
$1.7B
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COLL
COLL
FAT
FAT
Q4 25
$386.7M
Q3 25
$285.9M
Q2 25
$222.2M
Q1 25
$197.8M
Q4 24
$162.8M
Q3 24
$120.0M
Q2 24
$271.6M
Q1 24
$318.0M
Total Debt
COLL
COLL
FAT
FAT
Q4 25
Q3 25
$1.3B
Q2 25
$1.3B
Q1 25
$1.3B
Q4 24
$1.3B
Q3 24
$1.2B
Q2 24
$1.2B
Q1 24
$1.2B
Stockholders' Equity
COLL
COLL
FAT
FAT
Q4 25
$301.7M
Q3 25
$274.8M
$-585.8M
Q2 25
$232.2M
$-536.5M
Q1 25
$234.4M
$-493.9M
Q4 24
$228.8M
$-455.7M
Q3 24
$234.3M
$-386.1M
Q2 24
$216.6M
$-338.6M
Q1 24
$222.2M
$-296.8M
Total Assets
COLL
COLL
FAT
FAT
Q4 25
$1.7B
Q3 25
$1.6B
$1.2B
Q2 25
$1.6B
$1.2B
Q1 25
$1.6B
$1.3B
Q4 24
$1.7B
$1.3B
Q3 24
$1.6B
$1.3B
Q2 24
$1.1B
$1.4B
Q1 24
$1.1B
$1.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COLL
COLL
FAT
FAT
Operating Cash FlowLast quarter
$123.0M
$-14.5M
Free Cash FlowOCF − Capex
$122.4M
$-16.9M
FCF MarginFCF / Revenue
59.6%
-12.1%
Capex IntensityCapex / Revenue
0.3%
1.7%
Cash ConversionOCF / Net Profit
7.25×
TTM Free Cash FlowTrailing 4 quarters
$327.6M
$-75.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COLL
COLL
FAT
FAT
Q4 25
$123.0M
Q3 25
$78.4M
$-14.5M
Q2 25
$72.4M
$-26.9M
Q1 25
$55.4M
$-13.2M
Q4 24
$84.6M
$-10.4M
Q3 24
$-9.0M
$-3.2M
Q2 24
$67.4M
$-14.2M
Q1 24
$61.9M
$-28.4M
Free Cash Flow
COLL
COLL
FAT
FAT
Q4 25
$122.4M
Q3 25
$78.3M
$-16.9M
Q2 25
$72.4M
$-29.3M
Q1 25
$54.6M
$-17.8M
Q4 24
$84.1M
$-11.0M
Q3 24
$-9.2M
$-11.1M
Q2 24
$67.1M
$-24.4M
Q1 24
$61.4M
$-32.5M
FCF Margin
COLL
COLL
FAT
FAT
Q4 25
59.6%
Q3 25
37.4%
-12.1%
Q2 25
38.5%
-20.0%
Q1 25
30.7%
-12.5%
Q4 24
46.2%
-7.6%
Q3 24
-5.8%
-7.7%
Q2 24
46.2%
-16.1%
Q1 24
42.3%
-21.4%
Capex Intensity
COLL
COLL
FAT
FAT
Q4 25
0.3%
Q3 25
0.1%
1.7%
Q2 25
0.0%
1.6%
Q1 25
0.4%
3.2%
Q4 24
0.3%
0.4%
Q3 24
0.2%
5.5%
Q2 24
0.2%
6.7%
Q1 24
0.4%
2.7%
Cash Conversion
COLL
COLL
FAT
FAT
Q4 25
7.25×
Q3 25
2.49×
Q2 25
6.05×
Q1 25
22.92×
Q4 24
6.75×
Q3 24
-0.96×
Q2 24
3.44×
Q1 24
2.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

COLL
COLL

Segment breakdown not available.

FAT
FAT

Restaurant Sales$96.6M69%
Royalty$21.6M15%
Factory$9.6M7%
Advertising$9.1M7%
Franchisor$1.5M1%
Other$1.5M1%

Related Comparisons